ProMIS Neurosciences, Inc. (PMN)
15.85
-1.58
(-9.06%)
USD |
NASDAQ |
Mar 25, 16:00
15.85
0.00 (0.00%)
After-Hours: 16:15
ProMIS Neurosciences EPS Diluted (Quarterly) : -5.928 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Oncolytics Biotech, Inc. | -0.1032 |
| Aurinia Pharmaceuticals, Inc. | 1.526 |
| Edesa Biotech, Inc. | -0.2819 |
| Lexaria Bioscience Corp. | -0.0746 |
| Xenon Pharmaceuticals, Inc. | -1.314 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -11.58M |
| Total Expenses (Quarterly) | 11.58M |
| Enterprise Value | 22.08M |
| Earnings Yield | -85.67% |
| Normalized Earnings Yield | -104.47 |